Agenus (AGEN) Upgraded at BidaskClub


A number of other analysts have also weighed in on AGEN. Zacks Investment Research raised shares of Agenus from a "hold" rating to a "buy" rating and set a $4.50 target price on the stock in a report on Tuesday, January 9th.



from Biotech News